Edwards Lifesciences
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.About EW
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care.
EW Key Statistics
EW News
Edwards Lifesciences (NYSE:EW) First Quarter 2024 Results Key Financial Results Revenue: US$1.60b (up 9.5% from 1Q 2023). Net income: US$351.9m (up 3.3% from...
Edwards Lifesciences Corporation EW reported adjusted earnings per share (EPS) of 66 cents in first-quarter 2024, surpassing the Zacks Consensus Estimate by 3.1...
Canaccord lowered the firm’s price target on Edwards Lifesciences to $85 from $86 and keeps a Buy rating on the shares. The firm said TAVR sales were slightly b...
Analyst ratings
53%
of 32 ratingsMore EW News
Edwards Lifesciences (EW) reported $1.6 billion in revenue for the quarter ended March 2024, representing a year-over-year increase of 9.5%. EPS of $0.66 for th...
Revenue: Reported $1.6 billion, up 10% year-over-year, surpassing estimates of $1.568 billion. Net Income: Reported $351.9 million, falling short of estimates...
Edwards Lifesciences (EW) came out with quarterly earnings of $0.66 per share, beating the Zacks Consensus Estimate of $0.64 per share. This compares to earning...
Edwards Lifesciences (EW) stock edged higher late Thursday after the medical devices maker reported adjusted earnings of 66 cents per share and nearly $1.6 bill...
Loading... Loading... Financial giants have made a conspicuous bullish move on Edwards Lifesciences. Our analysis of options history for Edwards Lifesciences E...
Key Insights Using the 2 Stage Free Cash Flow to Equity, Edwards Lifesciences fair value estimate is US$76.62 With US$85.94 share price, Edwards Lifesciences...
